Who
Lauren Mastrocola
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Praxis Precision Medicines.
In numbers
- Trades disclosed
- 56
- Buys
- 1
- Sells
- 2
- Bought
- $5,790
- Sold
- $3.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Nov 2020
- Last trade
- 14 May 2026
- Last filed
- 19 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 19 May 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code A | $21K127 at $167.94 | filing |
| 14 May 2026filed 19 May 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code A | $21K127 at $167.94 | filing |
| 12 Jan 2026filed 13 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $95K344 at $275.74 | filing |
| 12 Jan 2026filed 13 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $95K344 at $275.74 | filing |
| 10 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $106K367 at $288.45 | filing |
| 10 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $106K367 at $288.45 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $10K35 at $292.63 | filing |
| 7 Jan 2026filed 9 Jan 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code F | $10K35 at $292.63 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,047 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —508 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,557 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,680 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —207 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,351 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,250 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code M | $52K1,047 at $49.50 | filing |
News
Avalo Therapeutics (NASDAQ:AVTX) versus Praxis Precision Medicines (NASDAQ:PRAX) Financial AnalysisPRAX · tickerreport.com · 16 Oct 2026Analyzing Lisata Therapeutics (NASDAQ:LSTA) & Praxis Precision Medicines (NASDAQ:PRAX)PRAX · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Lauren Mastrocola; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.